Gene usage and germ line homology in subsets using certain VH genes
VH gene and patient no. . | VH homology to germ line gene, % . | VL gene . | JL gene . | VL homology to germ line gene, % . | VL gene reading frame . |
|---|---|---|---|---|---|
| VH1-69 | |||||
| 15 | 100 | κA27 | 4 | 100 | F |
| 16 | 100 | λ2-17 | 3 | 100 | F |
| 17* | 100 | λ2-6 | 2 | 100 | F |
| 18 | 100 | κA3 | 2 | 100 | F |
| 19 | 100 | κA11 | 5 | 99.5 | F |
| 20 | 100 | κA23, κL23 | 1, 2 | 100, 99.5 | F, NF |
| 21 | 100 | κL12 | 1 | 100 | F |
| 22* | 100 | λ2-6 | 2 | 100 | F |
| 23 | 100 | λ2-17 | 2 | 100 | F |
| 24* | 100 | κA27 | 1 | 100 | F |
| 25 | 100 | λ1-17 | 3 | 100 | F |
| 26* | 100 | κA27 | 3 | 100 | F |
| 27* | 100 | κA27 | 1 | 100 | F |
| 28* | 100 | κA27 | 1 | 100 | F |
| 29† | 100 | κO8 | 4 | 100 | F |
| 30 | 100 | κA27 | 1 | 99.6 | F |
| 31 | 100 | κO8 | 4 | 99.5 | F |
| 32 | 100 | κA17 | 5 | 100 | NF |
| 33 | 100 | κO2 | 1 | 100 | F |
| 34 | 100 | λ1-13 | 3 | 100 | F |
| 61† | 100 | ND | ND | ND | ND |
| 72* | 100 | ND | ND | ND | ND |
| VH1-2 | |||||
| 35† | 90 | κA30 | 4 | 93.2 | NF |
| 36 | 100 | λ1-17 | 2 | 99.3 | F |
| 37 | 100 | κO2 | 2 | 100 | F |
| 38 | 100 | κL2 | 4 | 100 | F |
| 39* | 100 | κB3 | 4 | 100 | F |
| 40* | 100 | κA17 | 1 | 100 | F |
| 41* | 100 | κB3 | 2 | 100 | F |
| 42* | 100 | κB3 | 4 | 100 | F |
| 43 | 100 | κB3 | 2 | 100 | F |
| 44 | 100 | κL10 | 2 | 99.6 | NF |
| 60† | 88.3 | ND | ND | ND | ND |
| 69* | 100 | ND | ND | ND | ND |
| VH1-3 | |||||
| 45* | 100 | κO2 | 2 | 100 | F |
| 46* | 100 | κO2 | 1 | 100 | F |
| 47* | 100 | κO2, κB3 | 1, 4 | 100, 100 | F, NF |
| 48* | 100 | κO2, λ1-4 | 2 | 100, 99.6 | F, F |
| 49* | 100 | κO2 | 2 | 100 | F |
| 50 | 100 | κB3 | 1 | 100 | NF |
| 51* | 100 | κO2 | 2 | 100 | F |
| 52* | 100 | κO2 | 1 | 100 | F |
| 53 | 92.4 | κL12 | 2 | 100 | F |
| 64* | 100 | κO2 | 4 | 100 | F |
| 65* | 100 | κO2 | 1 | 100 | F |
| VH1-18 | |||||
| 54 | 100 | λ1-4 | 2 | 99.6 | F |
| 55 | 100 | κA27, κA2 | ND, 2 | 100, 100 | F, NF |
| 56* | 100 | κO2 | 1 | 100 | F |
| 57* | 100 | κO2 | 2 | 100 | F |
| 58 | 92.8 | λ2-14 | 3 | 99.1 | F |
| 59* | 100 | κO2, κL6 | 3, 1 | 100, 100 | F, F |
| VH4-39 | |||||
| 3 | 100 | κA3 | 4 | 100 | NF |
| 4 | 94.6 | λ2-14 | 2 | 98.1 | F |
| 5 | 94.2 | κL2 | 1 | 95.5 | F |
| 6* | 99.1 | κO2, κL2 | 2, 4 | 100, 98 | F, NF |
| 7* | 100 | κO2 | 2 | 100 | F |
| 8* | 100 | κA3 | 2 | 100 | ND |
| 9* | 100 | κO2 | 4 | 99.5 | F |
| 10* | 100 | κO2, κL12 | 4, 2 | 100, 100 | F, NF |
| 11 | 94.2 | κA3 | 4 | 97.5 | F |
| 12 | 100 | κL8 | 4 | 100 | F |
| 13 | 100 | κB3, κL19 | 1, 4 | 99.6, 100 | F |
| 14 | 100 | κL6 | 3 | 99.5 | F |
| VH4-34 | |||||
| 1† | 94.9 | κA27 | 5 | 95.1 | F |
| 2† | 95.8 | κA27 | 1 | 94.9 | F |
| 67† | 92.2 | κA17 | 2 | 100 | F |
| 68† | 93.6 | κA17 | 2 | 100 | F |
VH gene and patient no. . | VH homology to germ line gene, % . | VL gene . | JL gene . | VL homology to germ line gene, % . | VL gene reading frame . |
|---|---|---|---|---|---|
| VH1-69 | |||||
| 15 | 100 | κA27 | 4 | 100 | F |
| 16 | 100 | λ2-17 | 3 | 100 | F |
| 17* | 100 | λ2-6 | 2 | 100 | F |
| 18 | 100 | κA3 | 2 | 100 | F |
| 19 | 100 | κA11 | 5 | 99.5 | F |
| 20 | 100 | κA23, κL23 | 1, 2 | 100, 99.5 | F, NF |
| 21 | 100 | κL12 | 1 | 100 | F |
| 22* | 100 | λ2-6 | 2 | 100 | F |
| 23 | 100 | λ2-17 | 2 | 100 | F |
| 24* | 100 | κA27 | 1 | 100 | F |
| 25 | 100 | λ1-17 | 3 | 100 | F |
| 26* | 100 | κA27 | 3 | 100 | F |
| 27* | 100 | κA27 | 1 | 100 | F |
| 28* | 100 | κA27 | 1 | 100 | F |
| 29† | 100 | κO8 | 4 | 100 | F |
| 30 | 100 | κA27 | 1 | 99.6 | F |
| 31 | 100 | κO8 | 4 | 99.5 | F |
| 32 | 100 | κA17 | 5 | 100 | NF |
| 33 | 100 | κO2 | 1 | 100 | F |
| 34 | 100 | λ1-13 | 3 | 100 | F |
| 61† | 100 | ND | ND | ND | ND |
| 72* | 100 | ND | ND | ND | ND |
| VH1-2 | |||||
| 35† | 90 | κA30 | 4 | 93.2 | NF |
| 36 | 100 | λ1-17 | 2 | 99.3 | F |
| 37 | 100 | κO2 | 2 | 100 | F |
| 38 | 100 | κL2 | 4 | 100 | F |
| 39* | 100 | κB3 | 4 | 100 | F |
| 40* | 100 | κA17 | 1 | 100 | F |
| 41* | 100 | κB3 | 2 | 100 | F |
| 42* | 100 | κB3 | 4 | 100 | F |
| 43 | 100 | κB3 | 2 | 100 | F |
| 44 | 100 | κL10 | 2 | 99.6 | NF |
| 60† | 88.3 | ND | ND | ND | ND |
| 69* | 100 | ND | ND | ND | ND |
| VH1-3 | |||||
| 45* | 100 | κO2 | 2 | 100 | F |
| 46* | 100 | κO2 | 1 | 100 | F |
| 47* | 100 | κO2, κB3 | 1, 4 | 100, 100 | F, NF |
| 48* | 100 | κO2, λ1-4 | 2 | 100, 99.6 | F, F |
| 49* | 100 | κO2 | 2 | 100 | F |
| 50 | 100 | κB3 | 1 | 100 | NF |
| 51* | 100 | κO2 | 2 | 100 | F |
| 52* | 100 | κO2 | 1 | 100 | F |
| 53 | 92.4 | κL12 | 2 | 100 | F |
| 64* | 100 | κO2 | 4 | 100 | F |
| 65* | 100 | κO2 | 1 | 100 | F |
| VH1-18 | |||||
| 54 | 100 | λ1-4 | 2 | 99.6 | F |
| 55 | 100 | κA27, κA2 | ND, 2 | 100, 100 | F, NF |
| 56* | 100 | κO2 | 1 | 100 | F |
| 57* | 100 | κO2 | 2 | 100 | F |
| 58 | 92.8 | λ2-14 | 3 | 99.1 | F |
| 59* | 100 | κO2, κL6 | 3, 1 | 100, 100 | F, F |
| VH4-39 | |||||
| 3 | 100 | κA3 | 4 | 100 | NF |
| 4 | 94.6 | λ2-14 | 2 | 98.1 | F |
| 5 | 94.2 | κL2 | 1 | 95.5 | F |
| 6* | 99.1 | κO2, κL2 | 2, 4 | 100, 98 | F, NF |
| 7* | 100 | κO2 | 2 | 100 | F |
| 8* | 100 | κA3 | 2 | 100 | ND |
| 9* | 100 | κO2 | 4 | 99.5 | F |
| 10* | 100 | κO2, κL12 | 4, 2 | 100, 100 | F, NF |
| 11 | 94.2 | κA3 | 4 | 97.5 | F |
| 12 | 100 | κL8 | 4 | 100 | F |
| 13 | 100 | κB3, κL19 | 1, 4 | 99.6, 100 | F |
| 14 | 100 | κL6 | 3 | 99.5 | F |
| VH4-34 | |||||
| 1† | 94.9 | κA27 | 5 | 95.1 | F |
| 2† | 95.8 | κA27 | 1 | 94.9 | F |
| 67† | 92.2 | κA17 | 2 | 100 | F |
| 68† | 93.6 | κA17 | 2 | 100 | F |